October 29, 2024
A new publication by a research team including IMPACT Career Development Awardee, Andrew Kiselica, PhD, reveals findings from a survey conducted among clinical neuropsychologist with expertise in dementia care about the recently released diagnostic and staging criteria for Alzheimer’s disease recently released by an Alzheimer’s Association workgroup.
Participants rated their agreement with 15 statements about the Alzheimer’s Association’s draft criteria for AD on a 4-point Likert scale, with 1= Strongly Disagree to 4= Strongly Agree. Scores from the sixty-one analyzable responses indicate modest concern among participants with the recommendations. The area of most concern focused on barriers to implementing the recommendations, including a lack of healthcare resources and costs of biomarker testing.
Study findings suggest the need for important revisions or additions to the AA criteria for AD, including a clearer statement of purpose and more guidance on practical implementation.
Read more here.